Drug Infusion Systems Market Set to Reach $20.46 Billion by 2029 with 9% Yearly Growth

What market dynamics are playing a key role in accelerating the growth of the drug infusion systems market?
The escalation in the occurrence of chronic illnesses is projected to stimulate the expansion of the drug infusion system market. Long-term or ongoing infusion treatments are often needed for chronic diseases such as cancer, diabetes, cardiovascular disease, and autoimmune diseases. Drug infusion systems provide a secure, efficient, and impactful method for providing medication to patients suffering from these illnesses. It's notable that the rate at which these chronic illnesses are becoming prevalent is increasing more rapidly in lower to middle-income countries than in wealthier ones. Diabetes, for example, is a crucial catalyst for conditions like renal failure, heart attacks, strokes, blindness, and amputation of lower limbs. To illustrate, the Centers for Disease Control and Prevention (CDC), a US-based organization, reported in February 2024 that the proportion of Americans combating multiple chronic conditions is on the rise; 42% battling two or more and 12% grappling with five or more. Consequently, this surge in demand, coupled with the escalating prevalence of chronic diseases, is fueling the growth of the drug infusion system market.

Get Your Drug Infusion Systems Market Report Here:
https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

How will the growth rate of the drug infusion systems market shape industry trends by 2034?
The market size for drug infusion systems has been observing robust growth in the past few years. The sector, which stood at $13.42 billion in 2024, is projected to increase to $14.34 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.9%. The growth seen in the historic phase can be linked to the transition towards electronic infusion devices, a surge in chronic diseases, advancements in patient care, the adoption of home-based infusion therapy, and the development of ambulatory care settings.

The market size for drug infusion systems is anticipated to witness substantial growth in the upcoming years, escalating to "$20.46 billion by 2029 with a compound annual growth rate (CAGR) of 9.3%. This growth during the projected period is likely due to a shift towards disposable systems, an increasing occurrence of chronic diseases, expansion of ambulatory care facilities, personalized medicine, and adaptive dosing, coupled with a growing demand for home-based care. Prominent trends during the forecast period encompass wireless connectivity and remote monitoring, amalgamation with electronic health records (ehr), advancement in smart pump technology, personalized and adaptive dosing, as well as minimally invasive infusion methodologies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

What trends are poised to drive the future success of the drug infusion systems market?
Leading organizations in the drug infusion systems market are developing innovative technology such as cloud-based infusion management systems to boost patient care, increase precision and simplify infusion therapy management. These cloud-based management systems are digital tools enabling the monitoring, administration and tracking of medication infusions via the cloud. For instance, in June 2023, Eitan Medical, a globally recognized US-based organization specializing in advanced infusion therapy and drug delivery systems, unveiled Eitan Insights. This new cloud-based infusion management system caters to the specific requirements of home and specialty infusions. Eitan Insights equips healthcare professionals with up-to-the-minute data and analytics allowing remote patient monitoring and necessary adjustments to treatment plans. The system bolsters medication safety by minimizing errors and enhancing protocol compliance.

Which primary segments of the drug infusion systems market are driving growth and industry transformations?
The drug infusion systems market covered in this report is segmented -

1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System
2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration
3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

Subsegments:
1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps
2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components
3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps
4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps
5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies
6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps
7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps
8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10703

Which geographical regions are pioneering growth in the drug infusion systems market?
North America was the largest region in the drug infusion systems market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the influential players reshaping the drug infusion systems market landscape?
Major companies operating in the drug infusion systems market include Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton Dickinson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

What Is Covered In The Drug Infusion Systems Global Market Report?

• Market Size Forecast: Examine the drug infusion systems market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the drug infusion systems market for a structured understanding.
• Key Players Overview: Analyze major players in the drug infusion systems market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the drug infusion systems market.
• Segment Contributions: Evaluate how different segments drive overall growth in the drug infusion systems market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the drug infusion systems market.
• Industry Challenges: Identify potential risks and obstacles affecting the drug infusion systems market.
• Competitive Landscape: Review strategic developments in the drug infusion systems market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.